Boston Scientific is planning to purchase privately-held Preventice in a deal that could be worth up to $1.225 billion. The medical device maker announced this week that it has agreed to acquire Preventice Solutions, who offers a portfolio of mobile cardiac health services. The deal features a cash payment of $925 million up front and … Continue reading “Boston Scientific to Acquire Preventice for up to $1.225 Billion”
